Modulation of signaling between TM4SF5 and integrins in tumor microenvironment

Frontiers in Bioscience

Volumn 16, Issue 5, 2011, Pages 1751-1758

  Lee, Sin Ae ^a   Park, Ki Hun ^b   Lee, Jung Weon ^a  

^a Seoul National University   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

Cancer; Epithelial Mesenchymal Transition; Hepatocarcinoma; Integrin; Microenvironment; Review; TM4SF5

Indexed keywords

4 (4 TOLUENESULFONYLAMIDO) 4 HYDROXYCHALCONE; 4-(4-TOLUENESULFONYLAMIDO)-4-HYDROXYCHALCONE; ACTIN; CHALCONE; DRUG DERIVATIVE; INTEGRIN; MEMBRANE PROTEIN; SULFONAMIDE; TM4SF5 PROTEIN, HUMAN;

CANCER INVASION; CELL MOTION; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; TUMOR MICROENVIRONMENT;

ACTINS; CELL MOVEMENT; CELL PROLIFERATION; CHALCONE; EPITHELIAL-MESENCHYMAL TRANSITION; INTEGRINS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; SULFONAMIDES; TUMOR MICROENVIRONMENT;

EID: 79955013101     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3818     Document Type: Article

References (48)

1. Muller-Pillasch F., Wallrapp C., Lacher U., Friess H., Buchler M., Adler G. and Gress T. M.: Identification of a new tumour-associated antigen TM4SF5 and its expression in human cancer. Gene 208 (1), 25-30 (1998) (Pubitemid 28085272)
2. Wright M. D., Ni J. and Rudy G. B.: The L6 membrane proteins-a new four-transmembrane superfamily. Protein Sci 9 (8), 1594-1600 (2000) (Pubitemid 30659198)
3. Maecker H. T., Todd S. C. and Levy S.: The tetraspanin superfamily: molecular facilitators. FASEB Journal 11 (6), 428-442 (1997) (Pubitemid 27259984)
4. Seigneuret M., Delaguillaumie A., Lagaudriere-Gesbert C. and Conjeaud H.: Structure of the tetraspanin main extracellular domain. A partially conserved fold with a structurally variable domain insertion. J Biol Chem 276 (43), 40055-40064 (2001)
5. Wice B. M. and Gordon J. I.: A tetraspan membrane glycoprotein produced in the human intestinal epithelium and liver that can regulate cell density-dependent proliferation. J Biol Chem 270 (37), 21907-21918 (1995)
6. Lee S. A., Ryu H. W., Kim Y. M., Choi S., Lee M. J., Kwak T. K., Kim H. J., Cho M., Park K. H. and Lee J. W.: Blockade of four-transmembrane L6 family member 5 (TM4SF5)- mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative. Hepatology 49 (4), 1316-25 (2009)
7. Berditchevski F.: Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci 114 (Pt 23), 4143-4151 (2001) (Pubitemid 33138652)
8. Stipp C. S., Kolesnikova T. V. and Hemler M. E.: Functional domains in tetraspanin proteins. Trends Biochem Sci 28 (2), 106-112 (2003) (Pubitemid 36165140)
9. Berditchevski F. and Odintsova E.: Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling. J Cell Biol 146 (2), 477-492 (1999) (Pubitemid 29369782)
10. Lee S-Y, Kim YT, Lee M-S, Kim Y-B, Chung E, Kim S and Lee JW: Focal adhesion and actin organization by a cross-talk of TM4SF5 with integrin a2 are regulated by serum treatment. Experimental Cell Research 312 (16), 2983-2999 (2006) (Pubitemid 44292657)
11. Lee S. A., Lee S. Y., Cho I. H., Oh M. A., Kang E. S., Kim Y. B., Seo W. D., Choi S., Nam J. O., Tamamori- Adachi M., Kitajima S., Ye S. K., Kim S., Hwang Y. J., Kim I. S., Park K. H. and Lee J. W.: Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelialmesenchymal transition in human hepatocarcinoma. J Clin Invest 118 (4), 1354-1366 (2008) (Pubitemid 351500429)
12. Besson A., Gurian-West M., Schmidt A., Hall A. and Roberts J. M.: p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 18 (8), 862-876 (2004) (Pubitemid 38529656)
13. Moreno-Bueno G., Portillo F. and Cano A.: Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 27 (55), 6958-6969 (2008)
14. Kim H., Kang M., Lee S. A., Kwak T. K., Jung O., Lee H. J., Kim S. H. and Lee J. W.: TM4SF5 accelerates G1/S phase progression via cytosolic p27(Kip1) expression and RhoA activity. Biochim Biophys Acta 1803(8), 975-982 (2010)
15. Welsh C. F., Roovers K., Villanueva J., Liu Y., Schwartz M. A. and Assoian R. K.: Timing of cyclin D1 expression within G1 phase is controlled by Rho. Nat Cell Biol 3 (11), 950-957 (2001) (Pubitemid 34428739)
16. Pascual-Le Tallec L., Dulmet E., Bertagna X. and de Keyzer Y.: Identification of genes associated with the corticotroph phenotype in bronchial carcinoid tumors. J Clin Endocrinol Metab 87 (11), 5015-5022 (2002) (Pubitemid 35316340)
17. Kaneko R., Tsuji N., Kamagata C., Endoh T., Nakamura M., Kobayashi D., Yagihashi A. and Watanabe N.: Amount of expression of the tumor-associated antigen L6 gene and transmembrane 4 superfamily member 5 gene in gastric cancers and gastric mucosa. Am J Gastroenterol 96 (12), 3457-3458 (2001) (Pubitemid 34016692)
18. Gress T. M., Wallrapp C., Frohme M., Muller-Pillasch F., Lacher U., Friess H., Buchler M., Adler G. and Hoheisel J. D.: Identification of genes with specific expression in pancreatic cancer by cDNA representational difference analysis. Genes Chromosomes Cancer 19 (2), 97-103 (1997) (Pubitemid 27231484)
19. Friedl P. and Wolf K.: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3 (5), 362-374 (2003) (Pubitemid 37328856)
20. Lammerding J., Kazarov A. R., Huang H., Lee R. T. and Hemler M. E.: Tetraspanin CD151 regulates alpha6beta1 integrin adhesion strengthening. Proc Natl Acad Sci U S A 100 (13), 7616-7621 (2003) (Pubitemid 36760018)
21. Winterwood N. E., Varzavand A., Meland M. N., Ashman L. K. and Stipp C. S.: A critical role for tetraspanin CD151 in alpha3beta1 and alpha6beta4 integrin-dependent tumor cell functions on laminin-5. Mol Biol Cell 17 (6), 2707-2721 (2006) (Pubitemid 43825507)
22. Kohno M., Hasegawa H., Miyake M., Yamamoto T. and Fujita S.: CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. Int J Cancer 97 (3), 336-343 (2002) (Pubitemid 34049024)
23. Gimona M., Buccione R., Courtneidge S. A. and Linder S.: Assembly and biological role of podosomes and invadopodia. Curr Opin Cell Biol 20 (2), 235-241 (2008)
24. Lee S. A., Kim T. Y., Kwak T. K., Kim H., Kim S., Lee H. J., Kim S. H., Park K. H., Kim H. J., Cho M. and Lee J. W.: Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis. J Cell Biochem 111(1), 59-66 (2010)
25. Serrels B., Serrels A., Brunton V. G., Holt M., McLean G. W., Gray C. H., Jones G. E. and Frame M. C.: Focal adhesion kinase controls actin assembly via a FERMmediated interaction with the Arp2/3 complex. Nat Cell Biol 9 (9), 1046-1056 (2007) (Pubitemid 47338144)
26. Carmeliet P.: Angiogenesis in life, disease and medicine. Nature 438 (7070), 932-936 (2005) (Pubitemid 43093958)
27. Bergers G. and Benjamin L. E.: Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3 (6), 401-410 (2003) (Pubitemid 37328844)
28. Hynes R. O.: A reevaluation of integrins as regulators of angiogenesis. Nat Med 8 (9), 918-921 (2002) (Pubitemid 35033683)
29. Shih S. C., Zukauskas A., Li D., Liu G., Ang L. H., Nagy J. A., Brown L. F. and Dvorak H. F.: The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis. Cancer Res 69 (8), 3272-3277 (2009)
30. Takeda Y., Kazarov A. R., Butterfield C. E., Hopkins B. D., Benjamin L. E., Kaipainen A. and Hemler M. E.: Deletion of tetraspanin CD151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood 109 (4), 1524-1532 (2007) (Pubitemid 46239585)
31. Choi S., Lee S. A., Kwak T. K., Kim H. J., Lee M. J., Ye S. K., Kim S. H., Kim S. and Lee J. W.: Cooperation between integrin alpha5 and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity. Blood 113 (8), 1845-1855 (2009)
32. Hemler M. E., Mannion B. A. and Berditchevski F.: Association of TM4SF proteins with integrins: relevance to cancer. Biochimica et Biophysica Acta 1287 (2-3), 67-71 (1996) (Pubitemid 26189187)
33. Zhang X. A., Kazarov A. R., Yang X., Bontrager A. L., Stipp C. S. and Hemler M. E.: Function of the tetraspanin CD151- alpha6beta1 integrin complex during cellular morphogenesis. Mol Biol Cell 13 (1), 1-11 (2002) (Pubitemid 34106054)
34. Radford K. J., Thorne R. F. and Hersey P.: Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. J Immunol 158 (7), 3353-3358 (1997) (Pubitemid 127484053)
35. Miyake M., Koyama M., Seno M. and Ikeyama S.: Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med 174 (6), 1347-1354 (1991)
36. Domanico S. Z., Pelletier A. J., Havran W. L. and Quaranta V.: Integrin alpha6Abeta1 induces CD81- dependent cell motility without engaging the extracellular matrix migration substrate. Mol Biol Cell 8 (11), 2253-65 (1997) (Pubitemid 27469386)
37. Lagaudriere-Gesbert C., Le Naour F., Lebel-Binay S., Billard M., Lemichez E., Boquet P., Boucheix C., Conjeaud H. and Rubinstein E.: Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity. Cell Immunol 182 (2), 105-112 (1997) (Pubitemid 28133998)
38. Lee S. A., Kim Y. M., Kwak T. K., Kim H. J., Kim S., Kim S. H., Park K. H., Cho M. and Lee J. W.: The extracellular loop 2 of TM4SF5 inhibits integrin alpha2 on hepatocytes under collagen type I environment. Carcinogenesis 30 (11), 1872-1879 (2009)
39. Hanahan D. and Weinberg R. A.: The hallmarks of cancer. Cell 100 (1), 57-70 (2000) (Pubitemid 30046295)
40. Sadej R., Romanska H., Baldwin G., Gkirtzimanaki K., Novitskaya V., Filer A. D., Krcova Z., Kusinska R., Ehrmann J., Buckley C. D., Kordek R., Potemski P., Eliopoulos A. G., Lalani el N. and Berditchevski F.: CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium. Mol Cancer Res 7 (6), 787-798 (2009)
41. Baudoux B., Castanares-Zapatero D., Leclercq- Smekens M., Berna N. and Poumay Y.: The tetraspanin CD9 associates with the integrin alpha6beta4 in cultured human epidermal keratinocytes and is involved in cell motility. Eur J Cell Biol 79 (1), 41-51 (2000) (Pubitemid 30088474)
42. Cushman M. and Nagarathnam D.: Cytotoxicities of some flavonoid analogues. J Nat Prod 54 (6), 1656-1660 (1991)
43. Won S. J., Liu C. T., Tsao L. T., Weng J. R., Ko H. H., Wang J. P. and Lin C. N.: Synthetic chalcones as potential anti-inflammatory and cancer chemopreventive agents. Eur J Med Chem 40 (1), 103-112 (2005)
44. Sabzevari O., Galati G., Moridani M. Y., Siraki A. and O'Brien P. J.: Molecular cytotoxic mechanisms of anticancer hydroxychalcones. Chem Biol Interact 148 (1- 2), 57-67 (2004) (Pubitemid 38824661)
45. Kumar S. K., Hager E., Pettit C., Gurulingappa H., Davidson N. E. and Khan S. R.: Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents. J Med Chem 46 (14), 2813-2815 (2003) (Pubitemid 36775907)
46. Calliste C. A., Le Bail J. C., Trouillas P., Pouget C., Habrioux G., Chulia A. J. and Duroux J. L.: Chalcones: structural requirements for antioxidant, estrogenic and antiproliferative activities. Anticancer Res 21 (6A), 3949-3956 (2001) (Pubitemid 34229269)
47. Ducki S.: The development of chalcones as promising anticancer agents. IDrugs 10 (1), 42-46 (2007) (Pubitemid 46438282)
48. Karlsson E., Delle U., Danielsson A., Olsson B., Abel F., Karlsson P. and Helou K.: Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer. BMC Cancer 8, 254 (2008)